Pn-MAPS30plus: Clinical Trials

2 active not recruiting, 1 completed, 1 not yet recruiting. 4 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	4	Active not recruiting 2, Completed 1, Not yet recruiting 1

Follow Pn-MAPS30plus: new trials by email Literature Review of Pn-MAPS30plus trials Research Report on Pn-MAPS30plus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial	Phase 1	Not yet recruiting	GlaxoSmithKline	60	2027-01-25	2026-07-16
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial	Phase 1	Active not recruiting	GlaxoSmithKline	46	2026-05-15	2026-09-28
Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial	Phase 1	Active not recruiting	GlaxoSmithKline	122	2026-03-10	2026-10-27
A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial	Phase 1	Completed	GlaxoSmithKline	127	2025-08-12	2026-06-05

Conditions studied

Pneumonia, Bacterial (4)

Sponsors

GlaxoSmithKline (4)

Countries

Australia (2)  ·  South Africa (1)